JAC Advance Access originally published online on November 28, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 39-43
© 2003 The British Society for Antimicrobial Chemotherapy
Effect of extended-spectrum ß-lactamases on the susceptibility of Haemophilus influenzae to cephalosporins
School of Human Life Sciences, University of Tasmania, Launceston, Tasmania 7250, Australia
Received 10 July 2002; returned 4 September 2002; revised 12 September 2002; accepted 25 September 2002
The extended-spectrum ß-lactamases (ESBLs) TEM-3, TEM-4 and TEM-5 were cloned into Haemophilus influenzae. These recombinant strains exhibited cefotaxime MICs of 0.5, 0.25 and 0.12 mg/L for TEM-3, -4 and -5, respectively, and the MIC of cefaclor was 4.0 mg/L. These MICs are higher than those of ß-lactamase-negative strains, or those producing simple wild-type TEM-1 ß-lactamase, but not high enough to be categorized as resistant according to the breakpoints of the NCCLS. The clones were also categorized as susceptible using NCCLS disc diffusion methodology and interpretive criteria. This study shows that current NCCLS susceptibility testing methods may have difficulty in detecting ESBLs if they were to occur in H. influenzae.
Keywords: extended-spectrum ß-lactamase, TEM ß-lactamase
* Tel: +61-3-63-243323; Fax: +61-3-63-243658; E-mail: Stephen.Tristram{at}utas.edu.au
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. G. Tristram, M. J. Pitout, K. Forward, S. Campbell, S. Nichols, and R. J. Davidson Characterization of extended-spectrum {beta}-lactamase-producing isolates of Haemophilus parainfluenzae J. Antimicrob. Chemother., March 1, 2008; 61(3): 509 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tristram and J. G. Burdach Effect of cloned inhibitor-resistant TEM {beta}-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate J. Antimicrob. Chemother., November 1, 2007; 60(5): 1151 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tristram, M. R. Jacobs, and P. C. Appelbaum Antimicrobial Resistance in Haemophilus influenzae Clin. Microbiol. Rev., April 1, 2007; 20(2): 368 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bozdogan, S. Tristram, and P. C. Appelbaum Combination of altered PBPs and expression of cloned extended-spectrum {beta}-lactamases confers cefotaxime resistance in Haemophilus influenzae J. Antimicrob. Chemother., April 1, 2006; 57(4): 747 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tristram, R. Hawes, and J. Souprounov Variation in selected regions of blaTEM genes and promoters in Haemophilus influenzae J. Antimicrob. Chemother., September 1, 2005; 56(3): 481 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tristram, B. Bozdogan, and P. C. Appelbaum Disc diffusion-based screening tests for extended-spectrum {beta}-lactamases in Haemophilus influenzae J. Antimicrob. Chemother., April 1, 2005; 55(4): 570 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Galan, M.-I. Morosini, M.-R. Baquero, M. Reig, and F. Baquero Haemophilus influenzae blaROB-1 Mutations in Hypermutagenic {Delta}ampC Escherichia coli Conferring Resistance to Cefotaxime and {beta}-Lactamase Inhibitors and Increased Susceptibility to Cefaclor Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2551 - 2557. [Abstract] [Full Text] [PDF] |
||||


